Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy-Reference-Cited by-同舟云学术

Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy

Published:2005-07 Issue:7 Volume:46 Page:1007-1016
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Thomas X,Le QH,de Botton S,Raffoux E,Chelghoum Y,Pautas C,Dreyfus F,Dhedin N,Vekhoff A,Troncy J,Pigneux A,de Revel T,Reman O,Travade P,Thiebaut A,Guerci A,Elhamri M,Fenaux P,Dombret H,Michallet M

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190500084837

Reference38 articles.

1. Treatment of refractory and relapsed acute myelogenous leukemia

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and Treatment of Adult Acute Myeloid Leukemia Other than Acute Promyelocytic Leukemia;Neoplastic Diseases of the Blood;2017-09-22

2. Providing Personalized Prognostic Information for Adult Leukemia Survivors;Biology of Blood and Marrow Transplantation;2013-11

3. Diagnosis and Treatment of Adult Acute Myeloid Leukemia Other than Acute Promyelocytic Leukemia;Neoplastic Diseases of the Blood;2012-07-27

4. Auto-SCT for AML in second remission: CALGB Study 9620;Bone Marrow Transplantation;2009-03-16

5. Long-Term Disease-Free Survival After Gemtuzumab, Intermediate-Dose Cytarabine, and Mitoxantrone in Patients With CD33+Primary Resistant or Relapsed Acute Myeloid Leukemia;Journal of Clinical Oncology;2008-11-10